LVM-23904-81745
3 vaccinations
1 coded response
35 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 775 / TX
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
-
2020-12-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
-
2020-12-29
Survey response — day 14, dose 1MedDRA: Injection site erythema — Feeling: GoodFree text: Lingering erythema surrounding injection site not painful, not pruritic, not induratedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2021-09-25
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-03
- 2021-10-09
- 2021-10-17
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
- 2022-03-26
- 2022-09-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | Flu |
Free text
Release 1 — day 14, dose 1
Symptoms: Lingering erythema surrounding injection site not painful, not pruritic, not indurated
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release